Federal Register / Vol. 70, No.
194 / Friday, October 7, 2005 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 06–19, Review R13.
Date: October 27, 2005.
Time: 11 a.m. to 12 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (telephone Conference Call).
Contact Person: Sooyoun (Sonia) Kim, MS,
Associate SRA, Scientific Review Branch,
Division of Extramural Research, National
Inst. of Dental & Craniofacial Research,
National Institute of Health, Bethesda, MD
20892; (301) 594–4827.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 06–21 Review R13.
Date: November 2, 2005.
Time: 12:30 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Mary Kelly, Scientific
Review Specialist, National Institute of
Dental & Craniofacial Res., 45 Center Drive,
Natcher Bldg., RM 4AN38J, Bethesda, MD
20892–6402; (301) 594–4809;
mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: September 29, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20248 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Mental Health Special Emphasis Panel,
October 20, 2005, 8:30 a.m. to October
21, 2005, 3 p.m., Holiday Inn Select
Bethesda, 8120 Wisconsin Ave.,
Bethesda, MD, 20814 which was
published in the Federal Register on
September 9, 2005, 70 FR 53674–53675.
The dates and times of the meeting
are the same but the location has
changed to the Marriott Bethesda Suites,
6711 Democracy Boulevard, Bethesda,
MD. The meeting is closed to the public.
VerDate Aug<31>2005 18:27 Oct 06, 2005 Jkt 208001
58721
Dated: September 30, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20249 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (U.S.C. Appendix 2), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Member
Conflict
Date: October 6, 2005
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mark R. Green, PhD,
Deputy Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1431, mgren1@nida.nih.gov
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel
Date: November 8, 2005
Time: 11:05 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call)
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: September 30, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20253 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Advisory Committee on Research on
Women’s Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
on Research on Women’s Health
Date: November 9–10, 2005
Time: November 9, 2005, 9 a.m. to 5 p.m.
Agenda: Provide advice to the Office of
Research on Women’s Health (ORWH) on
appropriate research activities with respect to
women’s health and related studies to be
undertaken by the national research
institutes; to provide recommendations
regarding ORWH activities; to meet the
mandates of the office; and for discussion of
scientific issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Time: November 10, 2005, 9 a.m. to 12:30
p.m.
Agenda: Same as above.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Joyce Rudick, Director,
Programs & Management, Office of Research
on Women’s Health, Office of the Director,
National Institutes of Health, Building 1,
Room 201, Bethesda, MD 20892, (301) 402–
1770.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: http://
www4.od.nih.gov/orwh/, where an agenda
07OCN1
 58722 Federal Register / Vol. 70, No. 194 / Friday, October 7, 2005 / Notices
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immonodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 16, 2005.
Anthony M. Coelho, Jr.
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20224 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Renal and Urological
Studies integrated Review Group Cellular
and Molecular Biology of the Kidney Study
Section.
Date: October 17–18, 2005.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Shirley Hilden, PhD,
Scientific Review Administrator, Center for
Scientific Review, National institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7814, Bethesda, MD 20892, (301) 435–
1198, hildens@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Bioengineering Fellowships.
Date: October 19, 2005.
Time: 11 a.m. to 2 p.m.
VerDate Aug<31>2005 18:27 Oct 06, 2005 Jkt 208001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Khalid Masood, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5095H,
MSC 7854, Bethesda, MD 20892, 301–402–
3962, masoodk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Development of Methods for In Vivo Imaging
and Bioengineering Research.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Behrouz Shabestari, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7854, Bethesda, MD 20892, (301) 435–
2409, shabestb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Oncogenesis.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Joanna M. Watson, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046–G,
MSC 7804, Bethesda, MD 20892, (301) 435–
1048, watsonjo@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Host Interactions with Bacterial Pathogens
Study Section.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Timothy J. Henry, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3212,
MSC 7808, Bethesda, MD 20892, (301) 435–
1147, henryt@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Virology—B Study Section.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Robert Freund, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3200,
MSC 7848, Bethesda, MD 20892, (301) 435–
1050, freundr@csr.nih.gov.
PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM
Name of Committee: Center for Scientific
Special Emphasis Panel, Small Business
Medical Imaging: Ultrasound.
Date: October 24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Hector Lopez, DSC,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, (301) 435–
2392, lopezh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Neurophysiology, Devices and
Neuroprosthetics/Brain Disorders and
Clinical Neuroscience/SBIR.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Vinod Charles, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5196,
MSC 7846, Bethesda, MD 20892, (301) 435–
0902, charlesvi@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Cancer Genetics
Study Section.
Date: October 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, PhD, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
MSC 7804, Bethesda, MD 20892, (301) 451–
0132, zouzhiq@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business Cardiovascular Devices.
Date: October 24–25, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Roberto J. Matus, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
2204, matusr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurodegeneration, Neuroinflammation,
Oxidate Stress and Mitochondria.
Date: October 24–25, 2005.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Omni Shoreham, 2500 Calvert Street
NW., Washington, DC 20037.
Contact Person: Carole L. Jelsema, PhD,
Chief and Scientific Review Administrator,
07OCN1